retatrutide gip glp-1 glucagon receptor agonist Calling a “GLP-3” is usually a quick sign that you don't understand the underlying biology. Retatrutide is a NuSH-based triple agonist—it targets GLP-1, GIP, and receptors. Only one of those retatrutide triple agonist gip glp-1

Xanthopoulos A, Starling RC, Kitai T, Triposkiadis F

In December 2025, the FDA approved the first oral GLP-1 pill for weight management, and compounding pharmacies have introduced oral disintegrating tablet (ODT) formulations that bypass the digestive system entirely

Packages arrive with prefilled pens or syringes (depending on the drug) along with injection supplies and instructions

Annals of medicine

10.1161/JAHA.120.020301 6 BanK.Noyan-AshrafM

These FDA-approved peptides work the same way regardless of sex by mimicking the GLP-1 hormone to reduce hunger and cravings, per GoodRx, though a provider should still tailor dosing to an individual's health history and goals